View Email as a Web Page

Issue 9, September 2022

Welcome to September’s ME Support Digest. 

This edition includes information on submitting at least one version of a protocol or review not already in Editorial Manager, welcome wording on author submissions in RevMan Web, support for CRG, upcoming webinars for consumers and recruitment of new statistical editors.

Contents

  1. WARNING: Protocols and reviews in progress which are not in Editorial Manager
  2. Amended wording on the submission pop-up in RevMan Web
  3. Support for CRGs
  4. Upcoming webinars for consumers
  5. Methods Support Unit: appointment of 2 new Statistical Editors
  6. News
    a. Cochrane Neonatal
    b. Cochrane Common Mental Disorders

1. WARNING: Protocols and reviews in progress which are not in Editorial Manager

Do you have protocols and reviews in your group, where authors are actively working, but have not yet been invited to submit to Editorial Manager? Are you hoping to publish these protocols and reviews in the coming months (for UK groups, before March 2023)?

If so, please do get at least one submitted version into EM now.

Why?

We all know that working in EM can be challenging, and corresponding with authors and peer reviewers by email might seem an easier option. But here are 3 good reasons for getting a submission for every review in progress into EM.

1) Author declarations of interest. If your authors have never submitted a version to EM, their last declarations of interest made in Archie must now be out of date. If authors acquire an interest now, how can they declare it? Their Archie forms are inaccessible and if you haven't asked them to submit to EM, they won't have an account in Convey (our declaration of interest management system). Getting a submission into EM will ensure authors receive a request to declare their interests in Convey. Collecting interests well ahead of publication minimises the change of any unwanted disclosures once a submission is already in production. You are also ensuring your authors comply with the Conflict of Interest Policy (section 6.1) which requires annual declarations of interest for reviews in progress.

2) Peer reviewer contributions. When you manage peer review outside EM, you prevent peer and consumer reviewers from receiving the 500 Cochrane Membership points which they are due for every completed peer review task. This could mean some contributors are missing out on Cochrane Membership. Handling peer review in Editorial Manager ensures that contributions are recorded across our systems and peer reviewers are rewarded for their work.

3) Handover of submissions to Central Editorial Service. In the longer term, Cochrane Central Editorial Service will be managing the editorial process for all submitted protocols and reviews. For UK groups, this handover has already begun, and will complete in March 2023 (detailed timelines). If your protocols and reviews in progress are in EM, you are ensuring the submission history - peer review comments, editorial decisions, author responses - is visible to all. This will help ensure a smoother handover process for authors.

How?

To move a submission into EM, Initiate Proposal and invite authors to submit. You can submit directly on the authors' behalf if you wish. Submitting to EM will ensure authors are asked to declare interests. If you want authors to continue working, you can Submit Editor's Decision straight away, to send the submission back to the authors. When they are ready to submit, their submission will come in to EM as a revised version. You can then take any further actions such as inviting reviewers or sending to publication.

If you need any help with submitting to EM, please contact Cochrane Support. We will be happy to assist.

2. Amended wording on the submission pop-up in RevMan Web

The wording has been changed to make it clearer to authors that they require an invitation to submit to Editorial Manager. See below.

3. Support for CRGs

As we've shared previously, this webpage is available with information on support for UK CRGs from now through to March 2023. We will soon be in touch via email to coordinate the closing of open proposals and transfer of content to the Central Editorial Service.

4. Upcoming webinars for consumers

Cochrane has plans for communications to contributors in the upcoming months but MEs may also like to point their consumers to the following webinars which will be repeated on the same day at different times:

27th October 2022
Webinar 1 08:00 - 09:00 BST (This webinar will be conducted in English only)
Webinar 2 16:00 - 17:00 BST (This webinar will be largely conducted in English but there will be an opportunity to ask questions in Spanish, Portuguese, and French)

For more information, to check the time in your local time zone, and to register, please click here.

5. Methods Support Unit: appointment of 2 new Statistical Editors

The Methods Support Unit is pleased to announce the appointment of two new Statistical Editors: Sofia Tsokani and Afroditi Kanellopoulou.

Sofia holds a BSc in Mathematics and a MSc in Statistics and Operations Research, both obtained from the University of Ioannina. Her PhD is focused on evidence synthesis methods, with an emphasis on meta-analysis and network meta-analysis of diagnostic tests. She has been working as a research associate in biostatistics for the past four years; during this time period she was involved in several both methodological and empirical projects, mainly in the field of network meta-analysis. Her research interests encompass systematic reviews, and statistical modelling for meta-analysis and network meta-analysis of both interventions and diagnostic tests.

Afroditi is a biostatistician with a strong interest in cancer prevention and progression, evidence synthesis as well as causal inference methods. She was trained at National and Kapodistrian University of Athens, Greece, where she received a Bachelor’s in Mathematics and a Master’s in Biostatistics. Since 2019, she is a Research Associate at the Department of Hygiene and Epidemiology, University of Ioannina, Greece and a PhD candidate under the supervision of Associate Professor, Konstantinos Tsilidis. Her doctoral research is focused on the investigation of the associations between a wide range of non-therapeutic modifiable risk factors and colorectal cancer survival.

We look forward to continuing to offer statistical advice and guidance to members of the Cochrane community. Please contact Rachel Richardson, Methods Support Unit Manager, with requests for help.

6. News

a. Cochrane Neonatal

A warm welcome back to Jane Cracknell who rejoins the group as AME. Michelle Fiander continues as ME for the group. Pua (Makalapua Motu’apuaka) who was working with the group has now stepped down from working with Neonatal.

b. Cochrane Common Mental Disorders

We are sad to see another one of our community, Jess Hendon, ME for Cochrane Common Mental Disorders leave. Jess plans to go freelance so if anyone has any projects coming up, please feel free to contact Jess at jessica.l.hendon@gmail.com. Jess’s last day will be 30th September. We wish her all the best for the future.

Contact us

If you have any questions about any of the above items, or about any aspect of your ME role, regardless of your location, please contact us at support@cochrane.org

The Cochrane Managing Editor Support Team:

Anupa Shah & Liz Dooley

Copyright © 2022 Cochrane, All rights reserved.
Registered in England as a company limited by guarantee No. 03044323 Charity Number 1045921. Registered office: St Albans House 57-59 Haymarket London, SW1Y 4QX United Kingdom


You've received this email because you have an active Managing Editor or Assistant Managing Editor role. To update your communication preferences for this and other types of email please visit your Cochrane Account. If you have any questions please email support@cochrane.org  

This page uses cookies to offer a better browsing experience, analyze site usage, personalize content, and assist in our marketing efforts. You can change your settings by clicking on "Cookie Preferences."

Cookie Preferences   ▼

This is your setting for either accepting or rejecting cookies on our site. Select to either accept or reject cookies.